Top Markets
#1 Derive Derive +30.89%
#2 Audiera Audiera +14.85%
#3 The Bitcoin Bull The Bitcoin Bull +11.05%
#4 Cross Cross +9.87%
#5 Humanity Humanity +9.29%
#6 Gama Token Gama Token +9.21%
#7 Velvet Velvet +8.41%
#8 Geodnet Geodnet +7.61%
#9 Based Based +7.37%
#10 Perle Perle +7.21%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Pa Shun International Holdings Limited Pa Shun International Holdings Limited

Pa Shun International Holdings Limited

0574
Rank in Stocks #35823
Pa Shun International Holdings Limited, an investment holding company, engages... Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution and manufacturing businesses in the People's Republic of China. The company sells pharmaceutical products to wholesalers, hospitals, and other medical institutions in rural areas. It also sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017. The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Pa Shun International Holdings Limited operates as a subsidiary of Praise Treasure Limited.
Share Price
$0.00230267
Last synced: 2026-07-27
Market Cap
$3.40M
Change (1 day)
0.00%
Change (1 year)
-66.01%
Country
HK
Trade Pa Shun International Holdings Limited (0574)

Category

Healthcare
Revenue for Pa Shun International Holdings Limited (0574)
Revenue in Aug 2026 TTM: 0
According to Pa Shun International Holdings Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Pa Shun International Holdings Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US